The impact of MGMT methylation and IDH-1 mutation on long-term outcome for glioblastoma treated with chemoradiotherapy-Reference-Cited by-同舟云学术

The impact of MGMT methylation and IDH-1 mutation on long-term outcome for glioblastoma treated with chemoradiotherapy

Published:2016-08-15 Issue:10 Volume:158 Page:1943-1953
ISSN:0001-6268
Container-title:Acta Neurochirurgica
language:en
Short-container-title:Acta Neurochir

Author:

Millward Christopher P.,Brodbelt Andrew R.,Haylock Brian,Zakaria Rasheed,Baborie Atik,Crooks Daniel,Husband David,Shenoy Aditya,Wong Helen,Jenkinson Michael D.

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00701-016-2928-8.pdf

Reference40 articles.

1. Amelot A, De Cremoux P, Quillien V, Polivka M, Adle-Biassette H, Lehmann-Che J, Françoise L, Carpentier AF, George B, Mandonnet E, Froelich S (2015) IDH-Mutation is a weak predictor of long-term survival in glioblastoma patients. PLoS One 10(7):e0130596

2. Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A (2008) Analysis of the IDH1 codon 132 mutation in brain tumours. Acta Neuropathol 116(6):597–602

3. Bayley JP, Devilee P (2010) Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. barking up the right tree? Curr Opin Genet Dev 20(3):324–329

4. Brodbelt A, Greenberg D, Winters T, Williams M, Vernon S, Collins VP, on behalf of the (UK) National Cancer Information Network Brain Tumour Group (2014) Glioblastoma in England: 2007-2011. Eur J Cancer 51(4):533–542

5. Choudry NS, Shah AH, Ferraro N, Snelling BM, Bregy A, Madhavan K, Komotar RJ (2013) Predictors of long-term survival in patients with glioblastoma multiforme: advancements from the last quarter century. Cancer Invest 31:287–308

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of frailty, cognitive function, and age as prognostic factors for survival in patients with IDH1wild-type high-grade glioma;Journal of Psychosocial Oncology Research and Practice;2024-07

2. Extent of Resection Thresholds in Molecular Subgroups of Newly Diagnosed Isocitrate Dehydrogenase–Wildtype Glioblastoma;Neurosurgery;2024-04-30

3. Potential Diagnostic and Clinical Significance of Selected Genetic Alterations in Glioblastoma;International Journal of Molecular Sciences;2024-04-18

4. Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approach;Scientific Reports;2024-02-28

5. Cognitive functioning in a cohort of high-grade glioma patients;Radiology and Oncology;2023-06-01